ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      62,887.49
      -1.34%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. OKYO Pharma Ltd (OKYO)

      7. OKYO Pharma Ltd (OKYO) News

      OKYO OKYO Pharma Ltd

      1.4701
      0.0234 (1.62%)
      Apr 26 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      OKYO Pharma Ltd OKYO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0234 1.62% 1.4701 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      1.46 1.435 1.55 1.4701 1.4467
      more quote information »

      Recent News

      Date Time Source Heading
      4/08/202419:00GLOBEOKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
      4/02/202407:00GLOBEOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
      3/22/202407:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
      3/21/202407:00GLOBEOKYO Pharma to Host Key Opinion Leader Event to Discuss New..
      3/20/202407:00GLOBEOKYO Pharma to Release New and Comprehensive Data from Phase..
      2/09/202407:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
      2/09/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/09/202407:00GLOBEOKYO Pharma Receives FDA Approval of IND for OK-101 in..
      1/31/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/31/202407:00GLOBEOKYO Pharma Announces Distinguished Ophthalmologists with..
      1/08/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/08/202407:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
      1/05/202409:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/05/202409:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
      12/21/202307:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/20/202317:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      12/18/202316:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/04/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/04/202307:00GLOBEOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
      11/29/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/01/202316:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/31/202316:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      10/31/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/31/202307:00GLOBEOKYO Pharma Announces $5.84 Million Cash Raise and Payables..
      10/10/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/09/202311:34IHNWOKYO Pharma Announces Filing of an Investigational New Drug..
      10/09/202307:00GLOBEOKYO Pharma Announces Filing of an Investigational New Drug..
      10/05/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/05/202307:00GLOBEOKYO Pharma Announces Positive Safety Data Profile for the..
      9/15/202316:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/15/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/15/202307:00GLOBEOKYO Pharma Announces Closing of $4.0 Million Registered..
      9/15/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      9/14/202310:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/14/202310:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/14/202309:15GLOBEOKYO Pharma Announces Pricing of $4.0 Million Registered..
      9/14/202308:45GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
      9/13/202316:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      9/13/202316:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/13/202316:05GLOBEOKYO Pharma Announces Public Offering of Ordinary Shares
      9/08/202307:04IHNWOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
      9/08/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/08/202307:00GLOBEOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
      8/30/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/30/202307:00GLOBEOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
      8/29/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/29/202307:00GLOBEOKYO Pharma Limited Regains Compliance with Nasdaq Listing..
      8/25/202311:33EDGAR2Form 20-F/A - Annual and transition report of foreign..
      8/15/202309:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/15/202309:00GLOBEOKYO Pharma Limited Reports Annual Results for the Twelve..

      Your Recent History

      NASDAQ
      OKYO
      OKYO Pharma
      Delayed Upgrade Clock